You are here: Industry Insights > Genetics

News List

Engineering the Cure: Advancement in Molecular Biology is building better drugs Shruti Talashi
March 18, 2024
Molecular biology holds the capacity to impact nearly every facet of drug research, development, and utilization.
deCODE genetics: Monozygous but not identical prnasia
January 08, 2021
In the article, Differences between germline genomes of monozygotic twins, published in Nature Genetics today scientists at deCODE genetics searched for mutations that were present in only one of monozygotic twins.
Genetics has revolutionised patient selection for clinical trials expresspharma
July 01, 2020
How is genetics improving the sphere of drug discovery and development? In what ways has it helped in clinical research, target identification, drug safety testing, etc.? Give us a few real-world examples.
Regeneron, CCPM Enter Genetics Research Alliance contractpharma
May 12, 2020
Large-scale genomics initiative aims to advance human genetics and precision medicine.
New drugs more likely to be approved if backed up by genetics, says study europeanpharmaceuticalreview
December 16, 2019
A recent study has reported that a new drug candidate is more likely to be approved for use if it targets a gene known to be linked to the disease.
AHA News: Genetics May Help Predict the Right Blood Pressure Drug for You drugs
June 26, 2019
Genetics May Help Predict the Right Blood Pressure Drug for You.
Seattle Genetics and Astellas Announce Positive Topline Results from Pivotal Trial of Enfortumab Vedotin in Locally Advanced or Metastatic Urothelial Cancer drugs
April 11, 2019
BOTHELL, Wash. and TOKYO, March 28, 2019 /PRNewswire/ -- Seattle Genetics, Inc.
Six new licensing deals for drug and gene therapy development firm europeanpharmaceuticalreview
April 10, 2019
Oxford Genetics has won six new licensing deals for its scalable drug and gene therapy manufacturing in the synthetic biology sector…
Seattle Genetics' Adcetris posts double survival win fiercepharma
December 06, 2018
SAN DIEGO—Last month, Seattle Genetics scored an ultrafast FDA nod for Adcetris in patients with newly diagnosed peripheral T-cell lymphoma, and data presented at the American Society of Hematology annual meeting show why.
Researchers use polygene scores to treat psychiatric disorders biospectrum
November 06, 2018
Researchers used genetic tests to predict ultimate response to medications in patients suffering their first episode of schizophrenia. Rather than testing for a single gene, investigators used a relatively new approach called "polygenic risk scores.

Previous page 1 2 Next page